Sequentia Biotech launches Gaia, the first intuitive metagenomics SAAS tool
| Published by Sequentia Biotech
Sequentia Biotech, based at the Barcelona Science Park, recently developed Gaia, an online bioinformatics tool able to manage and analyze metagenomic data from any microbial community (bacteria, viruses and eukaryotes) generated by Next Generation Sequencing technologies (NGS) applied to human, animal and plant genetics. This is a new field of genomics that seeks to obtain and analyze genome sequences of the different microorganisms that make up a community through NGS technologies, without the need to isolate or grow such microorganisms in vitro. "This is an online bioinformatics tool that provides metagenomic data analysis from environmental samples, which is a major advantage, since it has been estimated that when using traditional methods, based on in vitro isolation and culture of microorganisms, between 90-99% of the microbes in the sample are lost" explains Walter Sanseverino, cofounder and CEO of Sequentia.
Gaia is the first tool to automatically integrate all hierarchic levels of taxonomic classification (from kingdom to subspecies) with functional classification, obtaining results in just 12 hours. It is also the first tool to allow users to compare samples in real time. Due to its graphical and intuitive interface and ease of use, Gaia does not require specialized training; any researcher who is not an expert in bioinformatics can use this software and easily evaluate the analysis of the results obtained. The combination of all these characteristics make for a much wider, faster and efficient metagenomic analysis. "Gaia's main innovation lies in that its functionality and performance are equal or superior to other software packages, but with greater speed and ease of use. In addition, Gaia is a SAAS tool (Software as a Service) and hence it does not require the installation of software in the server, unlike other programs that take up space and slow down the speed of user terminals", says Riccardo Aiese, co-founder and CSO of Sequentia Biotech.